Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126946671 | 12694667 | 1 | I | 20160816 | 20160824 | 20160829 | 20160829 | EXP | BR-FRESENIUS KABI-FK201605870 | FRESENIUS KABI | 42.34 | YR | M | Y | 0.00000 | 20160829 | PH | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126946671 | 12694667 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Intravenous (not otherwise specified) | Y | U | 78IG0133 | 65346 | 600 | MG | INJECTION | Q6H | ||||
| 126946671 | 12694667 | 2 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Y | U | 78IG0133 | 65346 | |||||||||
| 126946671 | 12694667 | 3 | C | GENTAMICIN. | GENTAMICIN | 1 | 0 | 240 | MG | QD | |||||||||
| 126946671 | 12694667 | 4 | C | DIPYRONE | DIPYRONE | 1 | 0 | 2 | G | Q6H | |||||||||
| 126946671 | 12694667 | 5 | C | TRAMADOL. | TRAMADOL | 1 | 0 | 100 | MG | Q6H | |||||||||
| 126946671 | 12694667 | 6 | C | MORPHINE | MORPHINE | 1 | 0 | 4 | MG | Q4H | |||||||||
| 126946671 | 12694667 | 7 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | 8 | MG | Q8H | |||||||||
| 126946671 | 12694667 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | 20 | MG | QD | |||||||||
| 126946671 | 12694667 | 9 | C | TRANSDERMAL NICOTINE | 2 | 0 | 21 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126946671 | 12694667 | 1 | Antibiotic prophylaxis |
| 126946671 | 12694667 | 2 | Compartment syndrome |
| 126946671 | 12694667 | 3 | Product used for unknown indication |
| 126946671 | 12694667 | 4 | Product used for unknown indication |
| 126946671 | 12694667 | 5 | Product used for unknown indication |
| 126946671 | 12694667 | 6 | Product used for unknown indication |
| 126946671 | 12694667 | 7 | Product used for unknown indication |
| 126946671 | 12694667 | 8 | Product used for unknown indication |
| 126946671 | 12694667 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126946671 | 12694667 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126946671 | 12694667 | Burning sensation | |
| 126946671 | 12694667 | Erythema | |
| 126946671 | 12694667 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126946671 | 12694667 | 1 | 20160815 | 20160816 | 0 |